Mu Z - Search Results

1

MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment.

Mu Z, Ma CM, Chen X, Cvetkovic D, Pollack A, Chen L. Mu Z, et al. Phys Med Biol. 2012 Jan 21;57(2):535-45. doi: 10.1088/0031-9155/57/2/535. Phys Med Biol. 2012. PMID: 22217916 Free PMC article.

2

Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination.

Mu Z, Hachem P, Agrawal S, Pollack A. Mu Z, et al. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):336-43. doi: 10.1016/j.ijrobp.2003.09.029. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751501

3

Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.

Stoyanova R, Hachem P, Hensley H, Khor LY, Mu Z, Hammond ME, Agrawal S, Pollack A. Stoyanova R, et al. Among authors: mu z. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1151-60. doi: 10.1016/j.ijrobp.2007.03.047. Int J Radiat Oncol Biol Phys. 2007. PMID: 17637390 Free PMC article.

4

MR-guided focused ultrasound: enhancement of intratumoral uptake of [³H]-docetaxel in vivo.

Chen L, Mu Z, Hachem P, Ma CM, Wallentine A, Pollack A. Chen L, et al. Among authors: mu z. Phys Med Biol. 2010 Dec 21;55(24):7399-410. doi: 10.1088/0031-9155/55/24/001. Epub 2010 Nov 19. Phys Med Biol. 2010. PMID: 21098923

5

Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation.

Mu Z, Hachem P, Agrawal S, Pollack A. Mu Z, et al. Prostate. 2004 Aug 1;60(3):187-96. doi: 10.1002/pros.20044. Prostate. 2004. PMID: 15176048

6

Antisense Bcl-2 sensitizes prostate cancer cells to radiation.

Mu Z, Hachem P, Pollack A. Mu Z, et al. Prostate. 2005 Dec 1;65(4):331-40. doi: 10.1002/pros.20303. Prostate. 2005. PMID: 16015611 Free PMC article.

7

Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.

Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon HW, Hanlon AL, Agrawal S, Pollack A. Mu Z, et al. Prostate. 2008 May 1;68(6):599-609. doi: 10.1002/pros.20731. Prostate. 2008. PMID: 18196567 Free PMC article.

8

PKA knockdown enhances cell killing in response to radiation and androgen deprivation.

Hensley HH, Hannoun-Levi JM, Hachem P, Mu Z, Stoyanova R, Khor LY, Agrawal S, Pollack A. Hensley HH, et al. Among authors: mu z. Int J Cancer. 2011 Feb 15;128(4):962-73. doi: 10.1002/ijc.25634. Epub 2010 Oct 19. Int J Cancer. 2011. PMID: 20960462 Free PMC article.

9

Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.

Udayakumar TS, Stoyanova R, Shareef MM, Mu Z, Philip S, Burnstein KL, Pollack A. Udayakumar TS, et al. Among authors: mu z. Mol Cancer Ther. 2016 Jun;15(6):1353-63. doi: 10.1158/1535-7163.MCT-15-0332. Epub 2016 Mar 4. Mol Cancer Ther. 2016. PMID: 26944919 Free PMC article.

10

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models.

Mu Z, Klinowska T, Dong X, Foster E, Womack C, Fernandez SV, Cristofanilli M. Mu Z, et al. J Exp Clin Cancer Res. 2014 May 30;33(1):47. doi: 10.1186/1756-9966-33-47. J Exp Clin Cancer Res. 2014. PMID: 24886365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

933 results

Search Page

Filters